1887

Abstract

For some time there has been evidence suggesting an interaction between human cytomegalovirus (HCMV) and (HIV) in the pathogenesis of AIDS. Here, the interaction of HCMV and HIV-1 was examined in monocyte/macrophage cells, two cell types known to be targets for both viruses . Infection experiments demonstrated that prior infection with HCMV impeded subsequent superinfection with HIV-1. In contrast, uninfected bystander cells within the population were still permissive for HIV-1 infection and were also found to express increased levels of Gag after HIV-1 superinfection. Analysis of CCR5, a co-receptor for HIV-1, on HCMV-infected and bystander cells showed a substantial loss of surface CCR5 expression on infected cells due to HCMV-induced reduction of total cellular CCR5. In contrast, uninfected bystander cells displayed increased surface CCR5 expression. Furthermore, the data suggested that soluble factor(s) secreted from HCMV-infected cells were responsible for the observed upregulation of CCR5 on uninfected bystander cells. Taken together, these results suggest that, whilst HCMV-infected monocytes/macrophages are refractory to infection with HIV-1, HCMV-uninfected bystander cells within a population are more susceptible to HIV-1 infection. On this basis, HCMV infection may contribute to the pathogenesis of HIV-1.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.81452-0
2006-08-01
2019-11-14
Loading full text...

Full text loading...

/deliver/fulltext/jgv/87/8/2171.html?itemId=/content/journal/jgv/10.1099/vir.0.81452-0&mimeType=html&fmt=ahah

References

  1. Algeciras-Schimnich, A., Vlahakis, S. R., Villasis-Keever, A., Gomez, T., Heppelmann, C. J., Bou, G. & Paya, C. V. ( 2002; ). CCR5 mediates Fas- and caspase-8 dependent apoptosis of both uninfected and HIV infected primary human CD4 T cells. AIDS 16, 1467–1478.[CrossRef]
    [Google Scholar]
  2. Asin, S., Bren, G. D., Carmona, E. M., Solan, N. J. & Paya, C. V. ( 2001; ). NF-κB cis-acting motifs of the human immunodeficiency virus (HIV) long terminal repeat regulate HIV transcription in human macrophages. J Virol 75, 11408–11416.[CrossRef]
    [Google Scholar]
  3. Baillie, J., Sahlender, D. A. & Sinclair, J. H. ( 2003; ). Human cytomegalovirus infection inhibits tumor necrosis factor alpha (TNF-α) signaling by targeting the 55-kilodalton TNF-α receptor. J Virol 77, 7007–7016.[CrossRef]
    [Google Scholar]
  4. Croitoru-Lamoury, J., Guillemin, G. J., Boussin, F. D. & 7 other authors ( 2003; ). Expression of chemokines and their receptors in human and simian astrocytes: evidence for a central role of TNFα and IFNγ in CXCR4 and CCR5 modulation. Glia 41, 354–370.[CrossRef]
    [Google Scholar]
  5. Curran, J. W., Morgan, W. M., Hardy, A. M., Jaffe, H. W., Darrow, W. W. & Dowdle, W. R. ( 1985; ). The epidemiology of AIDS: current status and future prospects. Science 229, 1352–1357.[CrossRef]
    [Google Scholar]
  6. Davis, M. G., Kenney, S. C., Kamine, J., Pagano, J. S. & Huang, E.-S. ( 1987; ). Immediate-early gene region of human cytomegalovirus trans-activates the promoter of human immunodeficiency virus. Proc Natl Acad Sci U S A 84, 8642–8646.[CrossRef]
    [Google Scholar]
  7. Donaghy, H., Gazzard, B., Gotch, F. & Patterson, S. ( 2003; ). Dysfunction and infection of freshly isolated blood myeloid and plasmacytoid dendritic cells in patients infected with HIV-1. Blood 101, 4505–4511.[CrossRef]
    [Google Scholar]
  8. Duclos, H., Elfassi, E., Michelson, S., Arenzana-Seisdedos, F., Hazan, U., Munier, A. & Virelizier, J. L. ( 1989; ). Cytomegalovirus infection and trans-activation of HIV-1 and HIV-2 LTRs in human astrocytoma cells. AIDS Res Hum Retroviruses 5, 217–224.[CrossRef]
    [Google Scholar]
  9. Fairley, J. A., Baillie, J., Bain, M. & Sinclair, J. H. ( 2002; ). Human cytomegalovirus infection inhibits epidermal growth factor (EGF) signalling by targeting EGF receptors. J Gen Virol 83, 2803–2810.
    [Google Scholar]
  10. Hariharan, D., Douglas, S. D., Lee, B., Lai, J.-P., Campbell, D. E. & Ho, W.-Z. ( 1999; ). Interferon-γ upregulates CCR5 expression in cord and adult blood mononuclear phagocytes. Blood 93, 1137–1144.
    [Google Scholar]
  11. Ho, W.-Z., Harouse, J. M., Rando, R. F., Gonczol, E., Srinivasan, A. & Plotkin, S. A. ( 1990; ). Reciprocal enhancement of gene expression and viral replication between human cytomegalovirus and human immunodeficiency virus type 1. J Gen Virol 71, 97–103.[CrossRef]
    [Google Scholar]
  12. Jault, F. M., Spector, S. A. & Spector, D. H. ( 1994; ). The effects of cytomegalovirus on human immunodeficiency virus replication in brain-derived cells correlate with permissiveness of the cells for each virus. J Virol 68, 959–973.
    [Google Scholar]
  13. Kotenko, S. V., Saccani, S., Izotova, L. S., Mirochnitchenko, O. V. & Pestka, S. ( 2000; ). Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc Natl Acad Sci U S A 97, 1695–1700.[CrossRef]
    [Google Scholar]
  14. Koval, V., Clark, C., Vaishnav, M., Spector, S. A. & Spector, D. H. ( 1991; ). Human cytomegalovirus inhibits human immunodeficiency virus replication in cells productively infected by both viruses. J Virol 65, 6969–6978.
    [Google Scholar]
  15. Koval, V., Jault, F. M., Pal, P. G., Moreno, T. N., Aiken, C., Trono, D., Spector, S. A. & Spector, D. H. ( 1995; ). Differential effects of human cytomegalovirus on integrated and unintegrated human immunodeficiency virus sequences. J Virol 69, 1645–1651.
    [Google Scholar]
  16. Lathey, J. L. & Spector, S. A. ( 1991; ). Unrestricted replication of human cytomegalovirus in hydrocortisone-treated macrophages. J Virol 65, 6371–6375.
    [Google Scholar]
  17. Lathey, J. L., Spector, D. H. & Spector, S. A. ( 1994; ). Human cytomegalovirus-mediated enhancement of human immunodeficiency virus type-1 production in monocyte-derived macrophages. Virology 199, 98–104.[CrossRef]
    [Google Scholar]
  18. Lecointe, D., Dugas, N., Leclerc, P., Hery, C., Delfraissy, J.-F. & Tardieu, M. ( 2002; ). Human cytomegalovirus infection reduces surface CCR5 expression in human microglial cells, astrocytes and monocyte-derived macrophages. Microbes Infect 4, 1401–1408.[CrossRef]
    [Google Scholar]
  19. Lei, J.-Q., Wu, C.-L., Wang, X.-L. & Wang, H.-H. ( 2005; ). p38 MAPK-dependent and YY1-mediated chemokine receptors CCR5 and CXCR4 up-regulation in U937 cell line infected by Mycobacterium tuberculosis or Actinobacillus actinomycetemcomitans. Biochem Biophys Res Commun 329, 610–615.[CrossRef]
    [Google Scholar]
  20. Meltzer, M. S., Nakamura, M., Hansen, B. D., Turpin, J. A., Kalter, D. C. & Gendelman, H. E. ( 1990; ). Macrophages as susceptible targets for HIV infection, persistent viral reservoirs in tissue, and key immunoregulatory cells that control levels of virus replication and extent of disease. AIDS Res Hum Retroviruses 6, 967–971.
    [Google Scholar]
  21. Moreno, T. N., Fortunato, E. A., Hsia, K., Spector, S. A. & Spector, D. H. ( 1997; ). A model system for human cytomegalovirus-mediated modulation of human immunodeficiency virus type 1 long terminal repeat activity in brain cells. J Virol 71, 3693–3701.
    [Google Scholar]
  22. Moriuchi, M. & Moriuchi, H. ( 2001; ). Octamer transcription factors up-regulate the expression of CCR5, a coreceptor for HIV-1 entry. J Biol Chem 276, 8639–8642.[CrossRef]
    [Google Scholar]
  23. Moriuchi, M. & Moriuchi, H. ( 2003; ). YY1 transcription factor down-regulates expression of CCR5, a major coreceptor for HIV-1. J Biol Chem 278, 13003–13007.[CrossRef]
    [Google Scholar]
  24. Moriuchi, H., Moriuchi, M. & Fauci, A. S. ( 1997; ). Cloning and analysis of the promoter region of CCR5, a coreceptor for HIV-1 entry. J Immunol 159, 5441–5449.
    [Google Scholar]
  25. Murphy, J. C., Fischle, W., Verdin, E. & Sinclair, J. H. ( 2002; ). Control of cytomegalovirus lytic gene expression by histone acetylation. EMBO J 21, 1112–1120.[CrossRef]
    [Google Scholar]
  26. Nelson, J. A., Reynolds-Kohler, C., Oldstone, M. B. & Wiley, C. A. ( 1988; ). HIV and HCMV coinfect brain cells in patients with AIDS. Virology 165, 286–290.[CrossRef]
    [Google Scholar]
  27. Percherancier, Y., Planchenault, T., Valenzuela-Fernandez, A., Virelizier, J.-L., Arenzana-Seisdedos, F. & Bachelerie, F. ( 2001; ). Palmitoylation-dependent control of degradation, life span, and membrane expression of the CCR5 receptor. J Biol Chem 276, 31936–31944.[CrossRef]
    [Google Scholar]
  28. Peterson, P. K., Gekker, G., Chao, C. C., Hu, S., Edelman, C., Balfour, H. H., Jr & Verhoef, J. ( 1992; ). Human cytomegalovirus-stimulated peripheral blood mononuclear cells induce HIV-1 replication via a tumor necrosis factor-α-mediated mechanism. J Clin Invest 89, 574–580.[CrossRef]
    [Google Scholar]
  29. Pleskoff, O., Tréboute, C., Brelot, A., Heveker, N., Seman, M. & Alizon, M. ( 1997; ). Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry. Science 276, 1874–1878.[CrossRef]
    [Google Scholar]
  30. Rando, R. F., Srinivasan, A., Feingold, J., Gonczol, E. & Plotkin, S. ( 1990; ). Characterization of multiple molecular interactions between human cytomegalovirus (HCMV) and human immunodeficiency virus type 1 (HIV-1). Virology 176, 87–97.[CrossRef]
    [Google Scholar]
  31. Reeves, M. B., MacAry, P. A., Lehner, P. J., Sissons, J. G. P. & Sinclair, J. H. ( 2005; ). Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers. Proc Natl Acad Sci U S A 102, 4140–4145.[CrossRef]
    [Google Scholar]
  32. Sinclair, J., Baillie, J., Bryant, L. & Caswell, R. ( 2000; ). Human cytomegalovirus mediates cell cycle progression through G1 into early S phase in terminally differentiated cells. J Gen Virol 81, 1553–1565.
    [Google Scholar]
  33. Sinzger, C., Kahl, M., Laib, K., Klingel, K., Rieger, P., Plachter, B. & Jahn, G. ( 2000; ). Tropism of human cytomegalovirus for endothelial cells is determined by a post-entry step dependent on efficient translocation to the nucleus. J Gen Virol 81, 3021–3035.
    [Google Scholar]
  34. Spencer, J. V., Lockridge, K. M., Barry, P. A., Lin, G., Tsang, M., Penfold, M. E. T. & Schall, T. J. ( 2002; ). Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10. J Virol 76, 1285–1292.[CrossRef]
    [Google Scholar]
  35. Suzuki, S., Miyagi, T., Chuang, L. F., Yau, P. M., Doi, R. H. & Chuang, R. Y. ( 2002; ). Chemokine receptor CCR5: polymorphism at protein level. Biochem Biophys Res Commun 296, 477–483.[CrossRef]
    [Google Scholar]
  36. Turtinen, L. W. & Seufzer, B. J. ( 1994; ). Selective permissiveness of TPA differentiated THP-1 myelomonocytic cells for human cytomegalovirus strains AD169 and Towne. Microb Pathog 16, 373–378.[CrossRef]
    [Google Scholar]
  37. Tyner, J. W., Uchida, O., Kajiwara, N. & 8 other authors ( 2005; ). CCL5–CCR5 interaction provides antiapoptotic signals for macrophage survival during viral infection. Nat Med 11, 1180–1187.[CrossRef]
    [Google Scholar]
  38. Varani, S., Frascaroli, G., Homman-Loudiyi, M., Feld, S., Landini, M. P. & Söderberg-Nauclér, C. ( 2005; ). Human cytomegalovirus inhibits the migration of immature dendritic cells by down-regulating cell-surface CCR1 and CCR5. J Leukoc Biol 77, 219–228.
    [Google Scholar]
  39. Walker, S., Hagemeier, C., Sissons, J. G. P. & Sinclair, J. H. ( 1992; ). A 10-base-pair element of the human immunodeficiency virus type 1 long terminal repeat (LTR) is an absolute requirement for transactivation by the human cytomegalovirus 72-kilodalton IE1 protein but can be compensated for by other LTR regions in transactivation by the 80-kilodalton IE2 protein. J Virol 66, 1543–1550.
    [Google Scholar]
  40. Webster, A. ( 1991; ). Cytomegalovirus as a possible cofactor in HIV disease progression. J Acquir Immune Defic Syndr 4 (Suppl. 1), S47–S52.
    [Google Scholar]
  41. Weinshenker, B. G., Wilton, S. & Rice, G. P. ( 1988; ). Phorbol ester-induced differentiation permits productive human cytomegalovirus infection in a monocytic cell line. J Immunol 140, 1625–1631.
    [Google Scholar]
  42. Weissman, D., Dybul, M., Daucher, M. B., Davey, R. T., Jr, Walker, R. E. & Kovacs, J. A. ( 2000; ). Interleukin-2 up-regulates expression of the human immunodeficiency virus fusion coreceptor CCR5 by CD4+ lymphocytes in vivo. J Infect Dis 181, 933–938.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.81452-0
Loading
/content/journal/jgv/10.1099/vir.0.81452-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error